查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1815433

2025年控制釋放藥物輸送全球市場報告

Controlled Release Drug Delivery Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年控制釋放給藥市場將快速成長，到2029年將達到1,172.4億美元，年複合成長率（CAGR）為12.8%。預測期內的成長可歸因於多種因素，例如向個人化醫療的轉變、為提高患者便利性而進行的技術整合、生技藥品和生物學名藥的擴張、新興地區的市場擴張以及聚合物科學的進步。預測期內的主要趨勢包括可生物分解和生物相容性材料、奈米技術的進步、個人化和標靶治療、植入式設備的進步以及創新的封裝技術。

未來五年的預測成長率為12.8%，較我們先前對該市場的預測略有下降0.3%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能給製劑設計師帶來重大挑戰，因為它可能會增加來自德國和比利時的控制釋放系統專用基質聚合物的成本，從而推遲緩釋性產品的上市，並增加藥物遞送技術方面的支出。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，關稅的影響也可能更加廣泛。

慢性病（也稱為非傳染性疾病 (NCD)）的盛行率不斷上升，預計將成為控制釋放藥物輸送市場擴張的主要驅動力。慢性病包括心臟病、癌症和糖尿病等疾病。這些疾病持續時間長，需要持續治療，並且常常限制日常活動。控制釋放藥物傳遞在這些慢性病的治療中起著至關重要的作用。有利於持續釋放藥物的藥物傳遞製劑對於需要長期治療或居住在醫療保健有限地區的患者尤其重要。例如，根據世界衛生組織 (WHO) 2022 年 9 月發布的報告，每年有 4,100 萬人死於慢性病，佔全球整體的 74%。約有 1700 萬人在 70 歲前死於慢性病。此外，77% 的慢性病死亡發生在中低收入國家，預計這一數字將繼續增加。因此，慢性病的日益普及正在推動控制釋放藥物輸送市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球控制釋放藥物傳遞：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球控制釋放藥物輸送市場：成長率分析
  • 全球控制釋放藥物輸送市場表現：規模與成長，2019-2024
  • 全球控制釋放藥物傳輸市場預測：規模與成長，2024-2029年，2034年
  • 全球控制釋放藥物輸送：總目標市場（TAM）

第6章 市場細分

  • 全球控制釋放藥物傳輸市場：依技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 沃斯特技術
  • 凝聚
  • 微膠囊化
  • 植入
  • 經皮
  • 定向投放
  • 其他技術
  • 全球控制釋放藥物傳遞市場：依釋放機制、實際狀況及預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基系統
  • 微儲庫分區控制藥物傳輸系統
  • 回饋控制藥物傳輸系統
  • 活化控制藥物輸送系統
  • 化學活化
  • 全球控制釋放藥物傳輸市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 定量噴霧吸入器
  • 注射
  • 經皮吸收貼片和眼用貼劑
  • 其他用途
  • 全球控制釋放藥物傳輸市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 個人
  • 研究
  • 其他最終用戶
  • 全球控制釋放藥物傳輸市場：按 Wurster 技術細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 噴塗
  • 流體化床包衣
  • 全球控制釋放藥物傳輸市場：依凝聚類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 簡單凝聚
  • 複合凝聚
  • 全球控制釋放藥物傳輸市場：按微膠囊類型細分、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基微膠囊
  • 脂質微膠囊化
  • 全球控制釋放藥物輸送市場：依植入物類型植入、實際結果及預測，2019-2024 年、2024-2029 年、2034 年
  • 可生物分解植入
  • 不可生物分解的植入
  • 全球控制釋放藥物輸送市場：按經皮給藥設備（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 微針貼片
  • 水庫系統
  • 矩陣系統
  • 全球控制釋放藥物輸送市場：按標靶輸送（按類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 奈米粒子
  • 抗體藥物複合體
  • 脂質體
  • 全球控制釋放藥物傳輸市場：按技術（其他）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 滲透泵浦
  • 原位凝膠體系

第7章 區域和國家分析

  • 全球控制釋放藥物輸送市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球控制釋放藥物輸送市場：依國家、實際結果及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 控制釋放藥物輸送市場：競爭格局
  • 控制釋放藥物輸送市場：公司簡介
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
    • Coating Place Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Corium International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Depomed Inc.
  • Pfizer Inc.
  • Aradigm Corporation
  • Capsugel LLC
  • GlaxoSmithKline plc
  • Bayer Healthcare LLC
  • Collegium Pharmaceuticals Inc.
  • GE HealthCare Technologies Inc.
  • Adare Pharmaceuticals Inc.
  • Allergan plc
  • Novartis AG
  • Lonza Group AG
  • Colorcon Inc.
  • SKY Pharmaceuticals Pvt. Ltd.
  • AstraZeneca plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年控制釋放藥物輸送市場：提供新機會的國家
  • 2029年控制釋放藥物輸送市場：細分領域帶來新機會
  • 2029年控制釋放藥物輸送市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r23277u

Controlled release drug delivery involves a dosage form designed to administer a medicine or medication in a specific manner, providing continuous and predictable kinetics for a predetermined duration.

The primary types of technology employed in controlled release drug delivery include the wurster technique, coacervation, microencapsulation, implants, transdermal delivery, targeted delivery, and others. The wurster technique, also known as fluid bed microencapsulation, encapsulates discrete particles in a fluidized bed using differential air flow to create cyclic movement of material. It encompasses various release mechanisms such as polymer-based systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation-modulated drug delivery systems, and chemically activated methods. These technologies find applications in metered dose inhalers, injectables, transdermal and ocular patches, among others. Major end-users include hospitals, clinics, individuals, research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The controlled release drug delivery market research report is one of a series of new reports from The Business Research Company that provides controlled release drug delivery market statistics, including controlled release drug delivery industry global market size, regional shares, competitors with a controlled release drug delivery market share, detailed controlled release drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the controlled release drug delivery industry. This controlled release drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The controlled release drug delivery market size has grown rapidly in recent years. It will grow from $65.44 billion in 2024 to $72.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to pioneering drug delivery systems, early polymer-based formulations, introduction of microencapsulation techniques, emergence of transdermal delivery, regulatory approvals, and standardization.

The controlled release drug delivery market size is expected to see rapid growth in the next few years. It will grow to $117.24 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to shift towards personalized medicine, technological integration for patient convenience, expansion of biologics and biosimilars, market expansion in developing regions, advancements in polymer science. Major trends in the forecast period include biodegradable and biocompatible materials, nanotechnology advancements, personalized medicine and targeted therapies, advances in implantable devices, innovative encapsulation techniques.

The forecast of 12.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for formulation scientists by increasing costs of specialized matrix polymers for controlled release systems sourced from Germany and Belgium, potentially delaying extended-release product launches and raising drug delivery technology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases, also termed noncommunicable diseases (NCDs), is projected to act as a significant driver for the expansion of the controlled release drug delivery market. Chronic diseases, which encompass ailments such as heart disease, cancer, and diabetes, persist over extended periods, necessitating ongoing medical attention and often restricting daily activities. Controlled-release drug delivery plays a pivotal role in treating such chronic conditions. Particularly for patients requiring prolonged treatment or residing in areas with limited healthcare access, drug delivery formulations facilitating extended medication release are paramount. For instance, a September 2022 report shared by the World Health Organization (WHO) highlighted that annually, 41 million people succumb to chronic diseases, accounting for 74 percent of global fatalities. Approximately 17 million individuals lose their lives to chronic ailments before reaching the age of 70. Moreover, 77 percent of deaths attributed to chronic diseases occur in low- and middle-income countries, with anticipated future increases. Thus, the escalating prevalence of chronic diseases fuels the growth of the controlled release drug delivery market.

The rising healthcare expenditure is projected to drive the growth of the controlled release drug delivery market in the coming years. Healthcare spending encompasses all financial resources-both public and private-allocated to the healthcare sector within a specific geographic area, country, or economy during a designated time frame. Investment in controlled release drug delivery is a multifaceted endeavor that includes the entire lifecycle of a medicinal product, from initial research to post-market monitoring, aimed at enhancing treatment outcomes, patient adherence, and overall healthcare efficiency. For instance, in May 2024, the Office for National Statistics, a UK-based statistics authority, reported that healthcare expenditure in the UK was approximately £292 billion in 2023, marking a nominal increase of 5.6%. Furthermore, long-term health and social care spending experienced a real-term growth of 2.8% in 2022. Consequently, the increasing healthcare spending is driving the growth of the controlled release drug delivery market.

Technological progression stands out as a pivotal trend gaining traction within the controlled-release drug delivery market. Major enterprises operating in this sector are embracing novel technologies to fortify their market positions. For example, in March 2022, Evonik Industries AG, a Germany-based pharmaceutical company, introduced UDRATEC SoluFlow. This innovative microparticle technology is engineered to enhance the solubility of active medicinal constituents in oral medication formulations. Utilizing an emulsion-based processing technique, UDRATEC SoluFlow overcomes solubility barriers unattainable through traditional production methods. This addition to Evonik Health Care's suite of oral drug delivery system solutions complements existing offerings such as oral excipients such as EUDRAGIT functional polymers, ready-to-fill functional capsules such as EUDRACAPTM, and various technologies and services aimed at optimizing medication performance.

Leading entities within the chocolate syrup market are strategically engaging in partnership initiatives, with a focus on broadening applications in the ophthalmic field. Strategic partnerships denote a collaborative process wherein companies leverage each other's strengths and resources to achieve mutual benefits and foster success. For instance, in March 2023, Hovione, a Portugal-based contract drug manufacturing company, unveiled a collaboration with Ripple Therapeutics Inc. to expand the utilization of Ripple's Epidel technology beyond its current ophthalmic applications. This partnership marks a pivotal step in extending the Epidel platform's reach beyond ophthalmology, combining technical synergy, innovative vision, and a harmonious cultural alignment. Hovione's proficiency in regulated, sustained drug administration, coupled with their expertise in chemical synthesis and pharmaceutical manufacturing, forms a robust foundation for this collaboration. Ripple Therapeutics Inc. operates as a Canada-based pharmaceutical firm.

In November 2022, Alcon, a Switzerland-based pharmaceuticals and medical devices company, completed the acquisition of Aerie Pharmaceuticals, Inc. for an undisclosed sum. This strategic acquisition signifies an expansion of Alcon's diverse range of commercial products and development pipeline within the realm of ophthalmic pharmaceuticals. Aerie Pharmaceuticals, Inc., an esteemed US-based company specializing in the manufacture of ophthalmic solutions, further bolsters Alcon's portfolio and advancements in the ophthalmic pharmaceutical sector through this acquisition.

Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the controlled release drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The controlled release drug delivery market consists of revenues earned by entities by providing services such as mucoadhesive drug delivery, implantable drug delivery, and gastro-retentive drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The controlled release drug delivery market also includes sales of nebulizers, infusion pumps, and other systems used to provide controlled release drug delivery. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Controlled Release Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on controlled release drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for controlled release drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The controlled release drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Wurster Technique; Coacervation; Micro Encapsulation; Implants; Transdermal; Targeted Delivery; Other Technologies
  • 2) By Release Mechanism: Polymer Based Systems; Micro Reservoir Partition Controlled Drug Delivery Systems; Feedback Regulated Drug Delivery Systems; Activation-Modulated Drug Delivery Systems; Chemically Activated;
  • 3) By Application: Metered Dose Inhalers; Injectable; Transdermal And Ocular Patches; Other Applications
  • 4) By End User: Hospitals; Clinics; Personal; Research; Other End Users
  • Subsegments:
  • 1) By Wurster Technique: Spray Coating; Fluid Bed Coating
  • 2) By Coacervation: Simple Coacervation; Complex Coacervation
  • 3) By Micro Encapsulation: Polymer-Based Micro Encapsulation; Lipid-Based Micro Encapsulation
  • 4) By Implants: Biodegradable Implants; Non-Biodegradable Implants
  • 5) By Transdermal: Microneedle Patches; Reservoir Systems; Matrix Systems
  • 6) By Targeted Delivery: Nanoparticles; Antibody-Drug Conjugates; Liposomes
  • 7) By Other Technologies: Osmotic Pumps; In Situ Gelling Systems
  • Companies Mentioned: Johnson & Johnson Services Inc.; Merck & Co. Inc.; Alkermes plc; Coating Place Inc.; Corium International Inc.; Depomed Inc.; Pfizer Inc.; Aradigm Corporation; Capsugel LLC; GlaxoSmithKline plc; Bayer Healthcare LLC; Collegium Pharmaceuticals Inc.; GE HealthCare Technologies Inc.; Adare Pharmaceuticals Inc.; Allergan plc; Novartis AG; Lonza Group AG; Colorcon Inc.; SKY Pharmaceuticals Pvt. Ltd.; AstraZeneca plc; Biogen Inc.; Orbis Biosciences Inc.; Alza Corporation; MicroCHIPS Inc.; Endo International plc; Heron Therapeutics Inc.; Intellipharmaceutics International Inc.; Ipsen Biopharmaceuticals Inc.; Luye Pharma Group Ltd.; Medtronic plc; Nektar Therapeutics; Novo Nordisk A/S; Ocular Therapeutix Inc.; Pacira BioSciences Inc.; Progenity Inc.; Sanofi S.A.; Teva Pharmaceutical Industries Ltd.; Titan Pharmaceuticals Inc.; Vectura Group plc; West Pharmaceutical Services Inc.; Zosano Pharma Corporation; Zynerba Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Controlled Release Drug Delivery Market Characteristics

3. Controlled Release Drug Delivery Market Trends And Strategies

4. Controlled Release Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Controlled Release Drug Delivery Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Controlled Release Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Controlled Release Drug Delivery Market Growth Rate Analysis
  • 5.4. Global Controlled Release Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Controlled Release Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Controlled Release Drug Delivery Total Addressable Market (TAM)

6. Controlled Release Drug Delivery Market Segmentation

  • 6.1. Global Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Other Technologies
  • 6.2. Global Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-Modulated Drug Delivery Systems
  • Chemically Activated
  • 6.3. Global Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Other Applications
  • 6.4. Global Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Peronal
  • Research
  • Other End Users
  • 6.5. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Wurster Technique, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spray Coating
  • Fluid Bed Coating
  • 6.6. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Coacervation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simple Coacervation
  • Complex Coacervation
  • 6.7. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Micro Encapsulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer-Based Micro Encapsulation
  • Lipid-Based Micro Encapsulation
  • 6.8. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biodegradable Implants
  • Non-Biodegradable Implants
  • 6.9. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Transdermal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microneedle Patches
  • Reservoir Systems
  • Matrix Systems
  • 6.10. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Targeted Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nanoparticles
  • Antibody-Drug Conjugates
  • Liposomes
  • 6.11. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Osmotic Pumps
  • In Situ Gelling Systems

7. Controlled Release Drug Delivery Market Regional And Country Analysis

  • 7.1. Global Controlled Release Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Controlled Release Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Controlled Release Drug Delivery Market

  • 8.1. Asia-Pacific Controlled Release Drug Delivery Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Controlled Release Drug Delivery Market

  • 9.1. China Controlled Release Drug Delivery Market Overview
  • 9.2. China Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Controlled Release Drug Delivery Market

  • 10.1. India Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Controlled Release Drug Delivery Market

  • 11.1. Japan Controlled Release Drug Delivery Market Overview
  • 11.2. Japan Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Controlled Release Drug Delivery Market

  • 12.1. Australia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Controlled Release Drug Delivery Market

  • 13.1. Indonesia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Controlled Release Drug Delivery Market

  • 14.1. South Korea Controlled Release Drug Delivery Market Overview
  • 14.2. South Korea Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Controlled Release Drug Delivery Market

  • 15.1. Western Europe Controlled Release Drug Delivery Market Overview
  • 15.2. Western Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Controlled Release Drug Delivery Market

  • 16.1. UK Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Controlled Release Drug Delivery Market

  • 17.1. Germany Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Controlled Release Drug Delivery Market

  • 18.1. France Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Controlled Release Drug Delivery Market

  • 19.1. Italy Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Controlled Release Drug Delivery Market

  • 20.1. Spain Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Controlled Release Drug Delivery Market

  • 21.1. Eastern Europe Controlled Release Drug Delivery Market Overview
  • 21.2. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Controlled Release Drug Delivery Market

  • 22.1. Russia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Controlled Release Drug Delivery Market

  • 23.1. North America Controlled Release Drug Delivery Market Overview
  • 23.2. North America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Controlled Release Drug Delivery Market

  • 24.1. USA Controlled Release Drug Delivery Market Overview
  • 24.2. USA Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Controlled Release Drug Delivery Market

  • 25.1. Canada Controlled Release Drug Delivery Market Overview
  • 25.2. Canada Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Controlled Release Drug Delivery Market

  • 26.1. South America Controlled Release Drug Delivery Market Overview
  • 26.2. South America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Controlled Release Drug Delivery Market

  • 27.1. Brazil Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Controlled Release Drug Delivery Market

  • 28.1. Middle East Controlled Release Drug Delivery Market Overview
  • 28.2. Middle East Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Controlled Release Drug Delivery Market

  • 29.1. Africa Controlled Release Drug Delivery Market Overview
  • 29.2. Africa Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Controlled Release Drug Delivery Market Competitive Landscape And Company Profiles

  • 30.1. Controlled Release Drug Delivery Market Competitive Landscape
  • 30.2. Controlled Release Drug Delivery Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Coating Place Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Corium International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Controlled Release Drug Delivery Market Other Major And Innovative Companies

  • 31.1. Depomed Inc.
  • 31.2. Pfizer Inc.
  • 31.3. Aradigm Corporation
  • 31.4. Capsugel LLC
  • 31.5. GlaxoSmithKline plc
  • 31.6. Bayer Healthcare LLC
  • 31.7. Collegium Pharmaceuticals Inc.
  • 31.8. GE HealthCare Technologies Inc.
  • 31.9. Adare Pharmaceuticals Inc.
  • 31.10. Allergan plc
  • 31.11. Novartis AG
  • 31.12. Lonza Group AG
  • 31.13. Colorcon Inc.
  • 31.14. SKY Pharmaceuticals Pvt. Ltd.
  • 31.15. AstraZeneca plc

32. Global Controlled Release Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Controlled Release Drug Delivery Market

34. Recent Developments In The Controlled Release Drug Delivery Market

35. Controlled Release Drug Delivery Market High Potential Countries, Segments and Strategies

  • 35.1 Controlled Release Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Controlled Release Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Controlled Release Drug Delivery Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer